Inobrodib (CCS-1477)

Skip to product information
1 of 1

Selleck Chemicals

SKU:S9667-5MG

Regular price €265,00 EUR
Regular price Sale price €265,00 EUR
Sale Sold out
Shipping calculated at checkout.
Size
Quantity
View full details

Inobrodib (CCS-1477) is an inhibitor of BET and MYC and related targets used in studies of Cell Cycle Regulation and Epigenetic Regulation and related signaling programs. It is especially relevant in cancer, endocrinology, and epigenetics models, where defined compound exposure can be linked to checkpoint control, mitotic progression, and proliferation timing and chromatin-state control, histone modification, and transcriptional regulation.

By inhibiting BET and MYC and related targets, Inobrodib (CCS-1477) can be used to examine checkpoint control, mitotic progression, and proliferation timing and chromatin-state control, histone modification, and transcriptional regulation. The epigenetic regulator annotation adds relevance to chromatin, epigenetic, and gene-expression profiling, together with downstream-response mapping in the same experimental setting. In cancer, endocrinology, and epigenetics models, these readouts can be combined with viability, reporter, localization, biochemical conversion, or morphology endpoints to refine experimental interpretation.

Research Applications

  • Target-focused assays involving BET and MYC and related targets
  • Pathway perturbation studies connected to Cell Cycle Regulation and Epigenetic Regulation and related signaling programs
  • Concentration-response inhibition and target-dependence studies
  • Chromatin, epigenetic, and gene-expression profiling

Overall, Inobrodib (CCS-1477) is appropriate when a defined chemical perturbant is needed to connect BET and MYC and related targets with measurable biochemical, transcriptional, electrophysiological, imaging, or phenotypic readouts in cancer, endocrinology, and epigenetics models. This profile is suited to mechanistic follow-up, comparative profiling, and assay optimization under defined exposure conditions.

Targets:
BET • MYC • Androgen Receptor
Target Class:
Epigenetic Regulator
Pathways:
Cell Cycle Regulation • Epigenetic Regulation • Hormone Signaling
Research Area:
Cancer • Endocrinology • Epigenetics
CAS No.:
2222941-37-7
Molecular Weight:
534.60
Formula:
C₃₀H₃₂F₂N₄O₃
SMILES:
CC1=C(C(=NO1)C)C2=CC3=C(C=C2)N(C(=N3)C4CCCC(=O)N4C5=CC(=C(C=C5)F)F)C6CCC(CC6)OC
Storage Temperature:
-20°C

For Research Use Only. Not intended for diagnostic or therapeutic use.
Products may be subject to intellectual property rights.

The purchase of this product does not grant any license for commercial use, manufacturing, or clinical applications. The user is responsible for ensuring compliance with applicable laws and third-party rights.